FDA Inspection
Regenerative Biologics, Inc.Regenerative Biologics, Inc. – FDA Inspection, Nov 5, 2024
Record Details
This FDA Inspection record concerns Regenerative Biologics, Inc., with an inspection on November 5, 2024, issued by the Florida District Office, covering biologics.
View Company Profile
ID · bea5c0d7-b2e0-4c92-b772-22fea7cf46d0
Inspection Facts
- Inspection number
- 1253781
- FDA center
- Biologics
Other FDA inspections of Regenerative Biologics, Inc.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| June 18, 2019 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| March 29, 2017 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| February 19, 2015 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| May 1, 2013 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| April 20, 2011 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Regenerative Biologics, Inc.
- FDA Inspection 1098286 - 2019-06-18
- FDA Inspection 1012244 - 2017-03-29
- FDA Inspection 914703 - 2015-02-19
- FDA Inspection 829781 - 2013-05-01
- FDA Inspection 721599 - 2011-04-20
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.